Do not go overboard with alcohol on semaglutide
GIP receptor signaling contributes through partly separate pathways: it influences energy balance, adipose-tissue handling of nutrients, and central appetite circuits, and it may temper the nausea that GLP-1 agonism can provoke
GLP-1 Agonists FDA-Approved for Weight Management Semaglutide (Wegovy) Wegovys approval at 2.4 mg weekly brought unprecedented weight loss efficacy to clinical practice
exclusively for research purposes and is not approved for human consumption
Zhu G, Pei L, Xia H, Tang Q, Bi F
Allergen-Free Options: Personalized compounding can accommodate dietary or medical restrictions, such as removing additives that may trigger allergic reactions